Hyperplastic polyposis syndrome: phenotypic diversity and association to colorectal cancer

被引:5
|
作者
Navarro, Matilde [1 ]
Gonzalez, Sara [2 ]
Iglesias, Silvia [1 ]
Capella, Gabriel [2 ]
Rodriguez-Moranta, Francisco [3 ]
Blanco, Ignacio [1 ]
机构
[1] Inst Catala Oncol, Unidad Consejo Genet, Programa Canc Hereditario, Barcelona, Spain
[2] Inst Catala Oncol, Unidad Diagnost Mol, Programa Canc Hereditario, Barcelona, Spain
[3] Hosp Univ Bellvitge, Serv Gastroenterol, Barcelona, Spain
来源
MEDICINA CLINICA | 2013年 / 141卷 / 02期
关键词
Hyperplastic polyps; Hyperplastic polyposis; Serrated polyposis; Colorectal cancer; SERRATED POLYPS; RISK; COLONOSCOPY; PATHWAYS; ADENOMAS;
D O I
10.1016/j.medcli.2012.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objetive: Hyperplastic polyposis syndrome (HPS) is an uncommon disorder characterized by hyperplastic polyps (HP) occasionally associated with serrated adenomas (SA) or mixed polyps (MP) and defined by clinical criteria (OMS/Cleveland). HPS is heterogeneous regarding the number and size of polyps, and it is associated with colorectal cancer (CRC) and a family history. Its genetic basis is unknow. We describe individuals with HPS criteria from a series of families assessed in our Unit of Genetic Advice for colonic polyposis. Our objective is to identify the clinical characteristics of this syndrome. Patients and methods: Retrospective study of 197 families with colonic polyposis (1998-2011), identifying patients with HPS criteria. To know the number of polyps, we took into account polypectomies and/or the histologic study of surgical samples. Polyps were classified into adenomas, serrated lesiones (HP and SA) and MP. Genetic studies revealed: microsatellite instability (MSI), MUTYH gene variants (p.Tyr165Cys, p.Gly382Asp and p.Glu396GlyfsX43) and APC gene. Results: Eighteen individuals, with a median age of 51.1 years, had criteria of HPS (11 M/7 F). Number of HP varied between 14 and 100 coexisting with classical adenomas, SA and MP in 14 individuals (77.8%). Localization of polyps: ascending and descending colon in 13 individuals (72.2%) and only descending colon in 5 (27.8%). A CRC was detected in 10/18 (55.6%) patients, and 3 of them had a double CRC, a family history in 3 patients (16.7%) and a history of HPS in one. IMS was not detected in 8 CRC nor in 3 adenomas studied; we detected 2/13 heterozygous mutations in the MUTYH gene (p.Gly382Asp) and one variant with an unknown biological significance in the APC gene (p.Ser926Pro). Conclusions: The phenotypic variability of HPS difficults its identification, hence it is important to adhere to the clinical criteria established for its classification as well as to establish screening guidelines for CRC on the basis of its high incidence. (C) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 50 条
  • [21] Hyperplastic polyposis syndrome: endoscopic imaging, phenotypic charcteristics and molecular pathways
    KS Boparai
    E Dekker
    CJM van Noesel
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [22] Hyperplastic gastric polyposis, hypergastrinemia and colorectal neoplasia: A new syndrome?
    Delpre, G
    Sperber, A
    Neeman, A
    Sandbank, J
    Krugliak, P
    Zirkin, H
    Fraser, G
    Niv, Y
    GUT, 1997, 41 : A9 - A9
  • [23] Hyperplastic polyposis syndrome
    Pox, C. P.
    Schmiegel, W.
    GASTROENTEROLOGE, 2012, 7 (06): : 518 - 521
  • [24] Phenotypic and molecular characteristics of hyperplastic polyposis
    Rashid, A
    Houlihan, PS
    Booker, S
    Petersen, GM
    Giardiello, FM
    Hamilton, SR
    GASTROENTEROLOGY, 2000, 119 (02) : 323 - 332
  • [25] Hyperplastic polyposis syndrome in asymptomatic patients: the results from the colorectal-cancer screening program
    Orlowska, J.
    Kiedrowski, M.
    Kaminski, F. M.
    Regula, J.
    Butruk, E.
    VIRCHOWS ARCHIV, 2009, 455 : 47 - 47
  • [26] Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome
    Boparai, K. S.
    Reitsma, J. B.
    Lemmens, V.
    van Os, T. A. M.
    Mathus-Vliegen, E. M. H.
    Koornstra, J. J.
    Nagengast, F. M.
    van Hest, L. P.
    Keller, J. J.
    Dekker, E.
    GUT, 2010, 59 (09) : 1222 - 1225
  • [27] Defining Phenotypes and Cancer Risk in Hyperplastic Polyposis Syndrome
    Kalady, Matthew F.
    Jarrar, Awad
    Leach, Brandie
    LaGuardia, Lisa
    O'Malley, Margaret
    Eng, Charis
    Church, James M.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (02) : 164 - 170
  • [28] Hyperplastic polyposis syndrome:: Phenotypic presentations and the role of MBD4 and MYH
    Chow, Elizabeth
    Lipton, Lara
    Lynch, Elly
    D'Souza, Rebecca
    Aragona, Clelia
    Hodgkin, Lindy
    Brown, Gregor
    Winship, Ingrid
    Barker, Melissa
    Buchanan, Daniel
    Cowie, Shannon
    Nasioulas, Steve
    du Sart, Desiree
    Young, Joanne
    Leggett, Barbara
    Jass, Jeremy
    Macrae, Finlay
    GASTROENTEROLOGY, 2006, 131 (01) : 30 - 39
  • [29] A Serrated Colorectal Cancer Pathway Predominates over the Classic WNT Pathway in Patients with Hyperplastic Polyposis Syndrome
    Boparai, Karam S.
    Dekker, Evelien
    Polak, Mirjam M.
    Musler, Alex R.
    van Eeden, Susanne
    van Noesel, Carel J. M.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (06): : 2700 - 2707
  • [30] Scarce information about the risk of cancer in colorectal hyperplastic polyps and polyposis
    Melato, M
    Rizzardi, C
    Nardon, E
    Stanta, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07): : 2267 - 2268